Drug Shortage Report for TEVA-IRBESARTAN HCTZ
| Report ID | 88174 |
| Drug Identification Number | 02330512 |
| Brand name | TEVA-IRBESARTAN HCTZ |
| Common or Proper name | IRBESARTAN HCTZ |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-02 |
| Estimated end date | 2019-11-30 |
| Actual end date | 2019-10-31 |
| Shortage status | Resolved |
| Updated date | 2019-11-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-07-02 | English | Compare |
| v2 | 2019-07-02 | French | Compare |
| v3 | 2019-07-03 | English | Compare |
| v4 | 2019-08-09 | English | Compare |
| v5 | 2019-08-09 | French | Compare |
| v6 | 2019-08-29 | English | Compare |
| v7 | 2019-08-29 | English | Compare |
| v8 | 2019-08-29 | French | Compare |
| v9 | 2019-09-26 | English | Compare |
| v10 | 2019-09-26 | French | Compare |
| v11 | 2019-10-31 | English | Compare |
| v12 | 2019-10-31 | French | Compare |
| v13 | 2019-11-01 | English | Compare |
Showing 1 to 13 of 13